Adeno-Associated Virus 9 Gene Therapy Granted Fast Track Status for CLN1 Disease - Infectious Disease Advisor

Adeno-Associated Virus 9 Gene Therapy Granted Fast Track Status for CLN1 Disease  Infectious Disease Advisor

The Food and Drug Administration has granted Fast Track designation to ABO-202, a one-time adeno-associated virus 9 gene therapy for the treatment of CLN1 ...